You are currently viewing Annuloplasty System Market Forecast To Reach $0.97 Billion By 2030: Key Trends Explained
Annuloplasty System Market Analysis

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Annuloplasty System Market CAGR Outlook And Future Development#_x000D_

The annuloplasty system market has shown robust expansion over recent years. Its valuation is projected to increase from $0.7 billion in 2025 to $0.75 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.0%. This market’s historical growth can be attributed to the rising prevalence of valvular heart diseases, the expansion of cardiac surgery programs, the increasing adoption of surgical valve repair instead of replacement, advancements in biomaterials for implants, and improvements in surgical training and techniques._x000D_

_x000D_

The annuloplasty system market is projected to experience substantial expansion in the coming years. This market is predicted to reach $0.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. Key drivers for this growth during the forecast period include the escalating demand for minimally invasive cardiac interventions, an expanding elderly demographic experiencing valve disorders, the increasing integration of robotic cardiac surgery, the broadening availability of transcatheter treatment options, and ongoing advancements in annuloplasty device technology. Prominent trends anticipated within this period encompass a greater acceptance of minimally invasive valve repair methodologies, the expanded application of robotic-assisted annuloplasty, a growing inclination towards adaptable and customizable annuloplasty devices, the proliferation of transcatheter annuloplasty systems, and a heightened emphasis on the sustained durability of heart valves._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=41675927&type=smp&name=Annuloplasty%20System%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR_x000D_

_x000D_

#Annuloplasty System Market Expansion Drivers: What’s Shaping Future Growth?#_x000D_

The growing occurrence of cardiovascular diseases is projected to drive the expansion of the annuloplasty system market in the future. These diseases encompass various conditions impacting the heart and blood vessels, such as coronary heart disease, heart failure, stroke, and high blood pressure. The rise in cardiovascular disease prevalence stems from an aging demographic, where age-related deterioration of the heart and blood vessels elevates the risk of cardiac issues. Annuloplasty systems assist in treating cardiovascular diseases by offering effective methods for heart valve repair, re-establishing correct valve operation, and enhancing blood circulation. These systems improve patient results through minimally invasive approaches to valve restoration, thereby shortening recovery periods and lowering surgical dangers. For example, in September 2023, data from the World Health Organization, a United Nations specialized agency based in Switzerland, showed 41 million deaths globally each year, accounting for 74% of fatalities from non-communicable diseases (NCDs) or chronic diseases. Among these, 17.9 million deaths were attributed to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes. Consequently, the increasing prevalence of cardiovascular diseases is a key factor boosting the growth of the annuloplasty system market._x000D_

_x000D_

#Annuloplasty System Market Segment Landscape: Which Areas Lead Development?#_x000D_

The annuloplasty system market covered in this report is segmented – _x000D_

_x000D_

1) By Device Type: Annular Rings And Bands, Suture Annuloplasty Devices_x000D_

2) By Procedure Type: Open Heart Surgery, Minimally Invasive Annuloplasty, Robotic Assisted Annuloplasty_x000D_

3) By Valve Type: Mitral Valve, Tricuspid Valves, Aortic Valves, Pulmonary Valves_x000D_

4) By End User: Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers_x000D_

_x000D_

Subsegments:_x000D_

1) By Annular Rings And Bands: Rigid Annuloplasty Rings, Semi-Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Complete Annuloplasty Rings, Incomplete Annuloplasty Rings_x000D_

2) By Suture Annuloplasty Devices: Adjustable Suture Annuloplasty Devices, Non-Adjustable Suture Annuloplasty Devices, Transcatheter Suture Annuloplasty Systems, Robotic-Assisted Suture Annuloplasty Devices_x000D_

_x000D_

#Annuloplasty System Market Strategic Trends: What Defines The Next Growth Phase?#_x000D_

Leading companies in the annuloplasty system market are prioritizing the development of innovative products, such as next-generation surgical valves and devices, to boost procedural efficiency and achieve better long-term patient outcomes. Next-generation surgical valves and devices are advanced, inventive medical tools designed to simplify implantation, reduce surgical complexity, and enhance the precision and durability of valve repairs or replacements. For example, in June 2024, Medtronic plc, a US-based medical technology company, launched the Avalus Ultra valve, which is a next-generation surgical aortic tissue valve. This innovative device simplifies implantation with its low-profile valve holder and durable polyetheretherketone (PEEK) base frame, improving surgical ease and long-term performance. It also enhances blood flow dynamics and provides visibility for future valve-in-valve procedures._x000D_

_x000D_

#Annuloplasty System Market Leading Players And Competitive Positioning#_x000D_

Major companies operating in the annuloplasty system market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, MicroPort Scientific Corporation, Terumo Corporation, B. Braun Melsungen AG, B. Braile Biomedica, Affluent Medical, Micro Interventional Devices Inc., NeoChord Inc., BioVentrix Inc., CryoLife Inc., Genesse BioMedical, BioStable Science & Engineering Inc., FOC Medical S.A., Cardiac Implants LLC, Medtentia International Ltd., Corcym S.r.l. _x000D_

_x000D_

#View The Full Annuloplasty System Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/annuloplasty-system-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR_x000D_

_x000D_

#Annuloplasty System Market Regional Distribution: Which Areas Power Market Growth?#_x000D_

North America was the largest region in the annuloplasty system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the annuloplasty system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model